NovaGo Therapeutics is a biotech start-up company dedicated to the development of human antibody therapeutics that promotes nerve repair and regeneration in the treatment of cerebral stroke and spinal cord injury by targeting Nogo-A. Nogo-A is the most potent inhibitor of nerve fiber regeneration.

Location
Facts & figures
  • Type of organization
    Private company
  • Year of foundation
    2015
  • Number of employees in Switzerland
    1-9
Key business